Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CISPLATIN Cause Type iv hypersensitivity reaction? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Type iv hypersensitivity reaction have been filed in association with CISPLATIN (CISplatin). This represents 0.0% of all adverse event reports for CISPLATIN.

15
Reports of Type iv hypersensitivity reaction with CISPLATIN
0.0%
of all CISPLATIN reports
1
Deaths
9
Hospitalizations

How Dangerous Is Type iv hypersensitivity reaction From CISPLATIN?

Of the 15 reports, 1 (6.7%) resulted in death, 9 (60.0%) required hospitalization, and 1 (6.7%) were considered life-threatening.

Is Type iv hypersensitivity reaction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does CISPLATIN Cause?

Off label use (4,359) Disease progression (3,746) Neutropenia (3,095) Febrile neutropenia (3,010) Nausea (2,923) Drug ineffective (2,608) Thrombocytopenia (2,565) Anaemia (2,530) Vomiting (2,326) Diarrhoea (2,022)

What Other Drugs Cause Type iv hypersensitivity reaction?

AMOXICILLIN (165) CLINDAMYCIN (128) INFLIXIMAB (120) CEFACLOR (101) IBUPROFEN (98) AMPICILLIN (97) VANCOMYCIN (97) CEPHALEXIN (92) AMOXICILLIN\CLAVULANIC ACID (89) CEFUROXIME (82)

Which CISPLATIN Alternatives Have Lower Type iv hypersensitivity reaction Risk?

CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE CISPLATIN vs CITALOPRAM CISPLATIN vs CITALOPRAM HYDROBROMIDE CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE CISPLATIN vs CITICOLINE

Related Pages

CISPLATIN Full Profile All Type iv hypersensitivity reaction Reports All Drugs Causing Type iv hypersensitivity reaction CISPLATIN Demographics